Aspirin use may not provide cardiovascular benefits for patients who have peripheral vascular disease, an analysis has found. Aspirin use may not provide cardiovascular benefits for patients who have ...
A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated, with fewer ...
CHICAGO — Semaglutide, a glucagon-like peptide (GLP-1) receptor agonist, has shown convincing benefits in yet another population: patients with peripheral arterial disease (PAD). In the STRIDE trial, ...
New findings from large-scale studies of more than 3.6 million people who underwent screening for cardiovascular disease reveals that a person's age and gender affects the prevalence of certain types ...
Please provide your email address to receive an email when new articles are posted on . Researchers presented a new subanalysis of the STRIDE trial. Ozempic improved walking distance in patients with ...
1 Research Institute for Sport and Exercise Science, Liverpool John Moores University, Liverpool, UK 2 School of Sport Science, Exercise and Health, The University of Western Australia, Crawley, ...